Showing results (2261-2270 of 2,664) with videos related to

Sort By:
Pageof 267
Neuron|February 24, 2019
Defining the Functional Role of NaV1.7 in Human NociceptionLucy A McDermott, Greg A Weir, Andreas C Themistocleous, et al.
Molecular Cancer Therapeutics|January 8, 2017
Combinatorial Drug Screening Identifies Ewing Sarcoma-specific SensitivitiesBranka Radic-Sarikas, Kalliopi P Tsafou, Kristina B Emdal, et al.
Medical Care|December 1, 2007
Development and validation of a short-form, rapid estimate of adult literacy in medicineAhsan M Arozullah, Paul R Yarnold, Charles L Bennett, et al.
Journal of Oncology Practice|April 20, 2013
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR reportBrian Chen, John Restaino, LeAnn Norris, et al.
Plos One|October 17, 2013
A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALLUwe Rix, Jacques Colinge, Katharina Blatt, et al.
Plos Pathogens|November 27, 2018
The RNA helicase DDX3X is an essential mediator of innate antimicrobial immunityDaniel Szappanos, Roland Tschismarov, Thomas Perlot, et al.
Research Square|February 27, 2024
The Anopheles coluzzii range extends into Kenya: Detection, insecticide resistance profiles and population genetic structure in relation to conspecific populations in West and Central AfricaLuna Kamau, Kelly L Bennett, Eric Ochomo, et al.
Ecological Applications : a Publication of the Ecological Society of America|August 27, 2014
Spatially explicit modeling of 1992-2100 land cover and forest stand age for the conterminous United StatesTerry L Sohl, Kristi L Sayler, Michelle A Bouchard, et al.
Cochlear Implants International|July 25, 2023
Electrode array positioning after cochlear reimplantation from single manufacturerMiriam R Smetak, Shanik J Fernando, Matthew R O'Malley, et al.
British Journal of Haematology|April 27, 2007
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysisAndrew M Evens, Jeffrey Cilley, Taylor Ortiz, et al.
Pageof 267